BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4400 related articles for article (PubMed ID: 394010)

  • 1. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
    Kalafut F; Cernák A; Pham Manh Hung
    Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
    Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
    Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of macrophage migration by choroidal malignant melanoma-associated antigens in patients with unveal melanoma.
    Manor RS; Livni E; Joshua H; Ben-Sira I
    Invest Ophthalmol Vis Sci; 1978 Jul; 17(7):684-7. PubMed ID: 352988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The leukocyte adherence inhibition test in malignant melanoma of the uvea].
    Klein J; Dieckhues B; Küchle HJ
    Fortschr Ophthalmol; 1982 Nov; 79(3):202-3. PubMed ID: 6764445
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
    Babusíková O; Babusík P; Novotná L
    Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological diagnosis of malignant melanomas of uveal tissue].
    Cernak A; Kalafut F; Hung PM
    Vestn Oftalmol; 1980; (5):60-3. PubMed ID: 7423736
    [No Abstract]   [Full Text] [Related]  

  • 16. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
    Kalafut F; Klobusická M; Novotná L
    Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
    Kalafut F; Hung PM; Novotná L; Grófová M
    Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 220.